The International Diabetes Federation (IDF) is the umbrella organization of over 200 national diabetes associations in over 160 countries. It represents the interests of the growing number of people with diabetes and those at risk. The Federation has been leading the global diabetes community since 1950, and IDF’s mission is to promote diabetes care, prevention, and a cure worldwide.
New figures from the 5th edition Diabetes Atlas (see http://www.idf.org/diabetesatlas) indicate that the number of people living with diabetes is expected to rise from 366 million in 2011 to 552 million by 2030. IDF also estimates that as many as 183 million people are unaware that they have diabetes.
The release of these figures follows the September meeting of 193 Heads of State and government officials at the UN High Level Meeting in New York to agree on a Political Declaration on Non-Communicable Diseases (NCDs) including diabetes. This marks a major milestone for diabetes and other NCDs. Ann Keeling, CEO, International Diabetes Federation (IDF) and Chair of the NCD Alliance stated:
“World leaders have recognized the magnitude and impact of these diseases and the urgent need for action … The Declaration will accelerate international progress on diabetes and NCDs, saving millions of people from preventable death and disability."
The growth in the diabetic market should be beneficial for the Health-e-Connect (HeC) System, which is the principal product of ALR Technologies ($ALRT). HeC is a web-based platform designed to assist healthcare providers caring for diabetes patients improve the compliance to and management of patient care plans through remote monitoring. Moreover, the system offers a solution to potentially reduce waste and cut costs to the healthcare system by electronically documenting or counting actual blood glucose test strip usage. Blood glucose test strips are a key element of self-monitoring of blood glucose (SMBG) and billions of dollars are spent each year on test strips for patients with diabetes. Through a unique communications channel, the ALRT HeC System’s platform also enables test strip suppliers to offer extra support to patients by encouraging them to be more compliant with their diabetes treatment plans. Adherence to prescribed treatment plans should improve health outcomes and reduce long-term healthcare costs by helping to prevent diabetes complications. The ALRT HeC System was successfully used in a clinical trial by type 2 diabetes patients on insulin as part of an intensive glucose monitoring program.
The HeC System supports data uploads from blood glucose meters manufactured by Abbott Diabetes Care, Bayer Diabetes Care, LifeScan Inc. (a Johnson & Johnson Company) and Roche Diabetes Care.
Down the road, ALRT plans to expand this platform to serve cover with other chronic diseases.
Disclaimer: UpGraded Strategies is in the business of providing journalism and social/digital media services as well as corporate information to create market and public awareness for publicly traded companies and do so through our website, social networks and affiliates. In this case with ALR Technologies Inc., UpGraded Strategies Inc. was provided with third party compensation through Viper Enterprises LLC. Viper Enterprises compensated UpGraded Strategies thirty five hundred dollars on November 23, 2011 for social and digital media strategy services for work done with ALR Technologies Inc. In some cases, the information is provided to us and we do all that we can to ensure the accuracy of the information, but cannot guarantee all information to be accurate. Information in our emails, press releases, message board postings and on our Web site may contain “forward looking statements” as defined under Section 27A of the Securities Act of 1933 and Section 21B of the Securities Exchange Act of 1934 and must be realized as such.